Worldwide Clinical Trials Selects Medidata to Streamline Clinical Site Reimbursements Across the Globe

NEW YORK–(BUSINESS WIRE)– Medidata
(NASDAQ:MDSO), the leading global provider of cloud-based technology and
data analytics for clinical research, today announced that after an
exhaustive 18 month selection process which encompassed all of the
leading site payments technologies, Worldwide Clinical Trials
(Worldwide) has selected Medidata Payments Cloud to streamline accurate,
timely payments on behalf of their clinical trial sponsors.

Medidata Payments Cloud is the industry’s only global site payment
technology that’s driven by EDC. Focused on executing predictable,
successful studies across a range of therapeutic areas, including
neuroscience, cardiovascular diseases, immune-mediated inflammatory
disorders (IMID) and rare diseases, Worldwide will leverage Medidata
Payments Cloud to automatically trigger, calculate and disburse payments
directly into an investigative site’s bank account. These capabilities
will further enable Worldwide to transform the CRO experience for
sponsors and sites – shortening payment cycle times, increasing accuracy
and eliminating hours allocated to reconciliation and reporting.

“Worldwide’s success as a CRO is down to our ability to partner
successfully with our trial sponsors and sites – going above and beyond
in the delivery, operation and support of all of our services,” said
Anthony Doyle, Chief Financial Officer, Worldwide. “Medidata Payments
Cloud stood out as a truly end-to-end solution, driven by EDC, and for
the opportunity it provides us to reimburse sites as quickly and
accurately as possible – important as we invest in processes and
technology that help Worldwide continue to stand out as a top-ranked
performer for service and customer loyalty.”

Medidata’s unified, cloud-based platform, including industry leading EDC
Rave which is fully integrated with Payments, is the only end-to-end
solution on the market with full support for global tax calculations and
disbursements to ensure accurate and timely payments. With on-demand
funding, Medidata Payments enables organizations to establish a more
robust financial strategy. In addition, companies are able to save
significant resources usually spent on reconciliation thanks to
real-time access to accrual and forecasting reports.

“Timeliness and accuracy in payments are critical to the success of
contract research organizations, and achieving both can be incredibly
challenging,” said April Mulroney, Managing Director of Payments at
Medidata. “We’re proud that Worldwide has selected Medidata Cloud
Payments, which will help them create an industry-leading site payment
operation, ensuring sites are easily paid on time, and reporting to
sponsors is accurate and timely.”

Connect with Medidata

• Read our blog, Geeks
  Talk Clinical
• Tweet this: .@worldwidetrials
  selects @Medidata to streamline global #clinicalsite reimbursements
  http://ow.ly/HVBF30dyhPi
• Follow us on Twitter: @Medidata
• Find us on LinkedIn

About Medidata

Medidata
is reinventing global drug and medical device development by creating
the industry’s leading cloud-based solutions for clinical research.
Through our advanced applications and intelligent data analytics,
Medidata helps advance the scientific goals of life sciences customers
worldwide, including more than 850 global pharmaceutical companies,
innovative biotech, diagnostic and device firms, leading academic
medical centers, and contract research organizations.

The Medidata Clinical Cloud^® brings a new level of quality
and efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled clinical
trial data assets provide deep insights that pave the way for future
growth. The Medidata Clinical Cloud is the primary technology solution
powering clinical trials for 18 of the world’s top 25 global
pharmaceutical companies and is used by 18 of the top 25 medical device
developers—from study design and planning through execution, management
and reporting.

About Worldwide Clinical Trials

Worldwide Clinical Trials employs more than 1,400 professionals around
the world, with offices in North and South America, Eastern and Western
Europe, Russia and Asia. Founded by physicians committed to advancing
medical science, Worldwide is out to change how the world experiences
CROs – in the best possible way. From early phase and bioanalytical
sciences through late phase and post-approval, we provide world-class,
full-service drug development services. With infrastructure and talent
spanning 60 countries, we execute predictable, successful studies with
operational excellence across a range of therapeutic areas, including
neuroscience, cardiovascular diseases, immune-mediated inflammatory
disorders (IMID) and rare diseases. We never compromise on science or
safety. We’re never satisfied with the status quo. We’re the Cure for
the Common CRO. For more information, visit
Worldwide.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170712005308/en/